Vimarsana
Biggest News Aggregation in the World

Roche Lucentis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Lucentis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Lucentis Today - Breaking & Trending Today

Regeneron answers rivals with data for new version of top-selling eye drug - Vimarsana News

Regeneron answers rivals with data for new version of top-selling eye drug

BioPharma

Opthea lines up $260M to show how eye drug compares to blockbuster AMD meds - Vimarsana News

Opthea lines up $260M to show how eye drug compares to blockbuster AMD meds

The wet form of age-related macular degeneration (AMD) is currently treated with eye drugs that are blockbuster sellers. Opthea Limited is developing a wet AMD drug that goes after different targets and the biotech struck a pair of financing deals that provide it with the cash for pivotal tests that could show how well its approach works.

Global Pharmaceutical Contract Manufacturing Market is - Vimarsana News

Global Pharmaceutical Contract Manufacturing Market is

 Visiongain has launched a new report on the Global Pharmaceutical Contract Manufacturing Market Forecast 2022-2032: - Market Segment by Services...

Regeneron, in search of an eye gene therapy, turns to a young biotech - Vimarsana News

Regeneron, in search of an eye gene therapy, turns to a young biotech

BioPharma

Novartis ups investment in gene therapy for the eye with $800M buyout - Vimarsana News

Novartis ups investment in gene therapy for the eye with $800M buyout

BioPharma